Remote CRA II for IBD Trials (Contract)

PSI CRO; Lisboa; Presencial; EUR 30 000 - 52 000; Tempo parcial

Resumo da oferta

PSI CRO is seeking a Clinical Research Associate II for a contract-based, home-based freelance position in Portugal. You will monitor sites, support startup, review CRFs, manage communications, and ensure data quality across multiple studies.

The role requires strong English/Portuguese skills and willingness to travel. Ideal candidates have at least 1 year of independent on-site monitoring in Portugal, experience with Phase II/III monitoring, and exposure to IBD studies.

Qualificações

• 1 year of independent on-site monitoring experience in Portugal.
• Experience in all types of monitoring visits in Phase II and/or III.
• Experience in IBD/Inflammatory Bowel Diseases is mandatory.
• Full working proficiency in English and Portuguese.
• Ability to travel.

Responsabilidades

• Conduct and report all types of onsite monitoring visits
• Be involved in study startup
• Perform CRF review, source document verification and query resolution
• Be responsible for site communication and management
• Supervise study activities, timelines, and schedules on the country level
• Be a point of contact for in-house support services and vendors
• Be involved in quality control, such as compliance monitoring and reports review
• Participate in feasibility research
• Support regulatory team in preparing documents for study submissions

Conhecimentos

On-site monitoring

English language

Portuguese language

Communication

Multitasking

Team collaboration

Travel flexibility

Formação académica

Bachelor's degree in Life Sciences

Ferramentas

MS Office

Descrição da oferta de emprego

PSI CRO is seeking a Clinical Research Associate II for a contract-based, home-based freelance position in Portugal. You will monitor sites, support startup, review CRFs, manage communications, and ensure data quality across multiple studies.

The role requires strong English/Portuguese skills and willingness to travel. Ideal candidates have at least 1 year of independent on-site monitoring in Portugal, experience with Phase II/III monitoring, and exposure to IBD studies.